Several novel medications are now available in the Britain for managing diabetes type 2 . Saxenda, Rybelsus , and Jardiance represent unique approaches, with copyright and Mounjaro being injectable incretin receptor activators primarily aimed at weight management alongside glucose stabilization, whi